Last reviewed · How we verify

Citomix — Competitive Intelligence Brief

Citomix (BINETRAKIN) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Lymphocyte Growth Factor [EPC]. Area: Immunology.

marketed Lymphocyte Growth Factor [EPC] Immunology Recombinant protein Live · refreshed every 30 min

Target snapshot

Citomix (BINETRAKIN) — Guna spa.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Citomix TARGET BINETRAKIN Guna spa marketed Lymphocyte Growth Factor [EPC]
Citomix INTERFERON Bayer Healthcare Pharms marketed Lymphocyte Growth Factor [EPC] 2015-01-01
Proleukin ALDESLEUKIN Chiron marketed Lymphocyte Growth Factor [EPC] Interleukin-2 receptor 1992-01-01
Cranberry Cranberry University of British Columbia marketed Lymphocyte Growth Factor [EPC]
Guna-Virus METENKEFALIN Guna spa marketed Lymphocyte Growth Factor [EPC]
Interferon-Gamma Interferon-Gamma SPP Pharmaclon Ltd. marketed Lymphocyte Growth Factor [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Lymphocyte Growth Factor [EPC] class)

  1. Guna spa · 2 drugs in this class
  2. Bayer Healthcare Pharms · 1 drug in this class
  3. Chiron · 1 drug in this class
  4. SPP Pharmaclon Ltd. · 1 drug in this class
  5. University of British Columbia · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Citomix — Competitive Intelligence Brief. https://druglandscape.com/ci/binetrakin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: